The VISION ACTion team are developing new functional testing methods, biomarkers, and treatments for diseases that cause sight-threatening damage to the eye and brain. The idea is to detect issues earlier and apply effective treatments. Preventative therapeutics are also being investigated. Vision ACTion is working with its commercial and academic Partners to achieve these outcomes. We have a number of disease focus areas including age related macular degeneration (AMD), Amblyopia, diabetic retinopathy, glaucoma, myopia and multiple sclerosis. For more information please contact us.